The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies

被引:93
作者
Ibsen, PH
机构
[1] Bacterial Vaccines Department, Statens Seruminstitut, DK-2300 Copenhagen S
关键词
pertussis toxin; detoxification; monoclonal antibodies; epitopes; solid- and soluble-phase ELISA;
D O I
10.1016/0264-410X(95)00230-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The effect of detoxification of pertussis toxin (PT) for vaccine usage by either generic manipulation, hydrogen peroxide or formaldehyde treatment on epitope recognition by a large collection of murine monoclonal pertussis toxin antibodies (PT MAbs) was assessed in a solid-phase and a soluble phase enzyme-linked immunosorbent assay (ELISA). The MAb binding patterns were found to be different in the two assays as the immobilization step appeared to cause conformational alterations in the native as well as the toxoided forms of PT According to the solid-phase ELISA, genetic, hydrogen peroxide and 0.35% formaldehyde detoxification of PT resulted in reduced epitope binding in 2.9, 31.4 and 78.1% of the MAbs, respectively In the soluble-phase ELISA, in which the MAbs were allowed to react with the toxoids or native toxin in solution, the percentages of MAbs showing decreased binding activity were 9.1, 50.0 and 71.4%, respectively. Stabilization of native PT and the genetically inactivated PT by 0.035% formaldehyde reduced the epitope binding activity in 50.0 and 8.7% of the MAbs, respectively. Increased antibody binding in the soluble-phase ELISA was observed in some of the toxoids: this ranged from 0% in the 0.35% formaldehyde-treated PT to 13.6% in the hydrogen peroxide-treated and 27.3% in the genetically detoxified PT. Regarding the effects of detoxification on epitopes recognized by PT-neutralizing MAbs in the soluble-phase ELISA, we found that treatment of PT with either 0.035%, 0.35% formaldehyde or hydrogen peroxide induced impairment of epitope binding in 72.7, 81.8 and 45.5% of the MAbs, respectively. In the genetically inactivated PT, the epitopes recognized by the neutralizing MAbs either appeared to remain intact or to show increased MAb binding activity. The epitope-binding patterns of several PT MAbs with mouse-protective properties varied considerably and were shown to be dependent out the detoxification procedure employed. The relevance of epitope alterations on PT as a vaccine component is discussed The results of the present study may have important implications for future quality assessment of PT for use in acellular pertussis vaccines. Copyright (C) 1996 Elsevier Science Ltd
引用
收藏
页码:359 / 368
页数:10
相关论文
共 36 条
[1]  
[Anonymous], 1988, LANCET, Vi, P955
[2]  
BARKIN RM, 1979, PEDIATRICS, V63, P256
[3]   PROTEIN-CHEMICAL ANALYSIS OF PERTUSSIS TOXIN REVEALS HOMOLOGY BETWEEN THE SUBUNITS S2 AND S3, BETWEEN S1 AND THE A-CHAINS OF ENTEROTOXINS OF VIBRIO-CHOLERAE AND ESCHERICHIA-COLI AND IDENTIFIES S2 AS THE HAPTOGLOBIN-BINDING SUBUNIT [J].
CAPIAU, C ;
PETRE, J ;
VANDAMME, J ;
PUYPE, M ;
VANDEKERCKHOVE, J .
FEBS LETTERS, 1986, 204 (02) :336-340
[4]   IDENTIFICATION OF T-CELL AND B-CELL EPITOPES OF THE S2-SUBUNIT AND S3-SUBUNIT OF PERTUSSIS TOXIN BY USE OF SYNTHETIC PEPTIDES [J].
CHONG, P ;
ZOBRIST, G ;
SIA, C ;
LOOSMORE, S ;
KLEIN, M .
INFECTION AND IMMUNITY, 1992, 60 (11) :4640-4647
[5]  
CODY CL, 1981, PEDIATRICS, V68, P650
[6]   ANTIGENIC STRUCTURE OF POLIOVIRUS IN INACTIVATED VACCINES [J].
FERGUSON, M ;
WOOD, DJ ;
MINOR, PD .
JOURNAL OF GENERAL VIROLOGY, 1993, 74 :685-690
[7]  
FINE PEM, 1987, REV INFECT DIS, V9, P866
[8]  
FISH F, 1984, INFECT IMMUN, V44, P1
[9]   THE STANDARDIZATION OF AN ASSAY FOR PERTUSSIS TOXIN AND ANTITOXIN IN MICROPLATE CULTURE OF CHINESE-HAMSTER OVARY CELLS [J].
GILLENIUS, P ;
JAATMAA, E ;
ASKELOF, P ;
GRANSTROM, M ;
TIRU, M .
JOURNAL OF BIOLOGICAL STANDARDIZATION, 1985, 13 (01) :61-&
[10]   IMMUNOGENICITY OF A 5-COMPONENT ACELLULAR PERTUSSIS-VACCINE IN INFANTS AND YOUNG-CHILDREN [J].
HALPERIN, SA ;
BARRETO, L ;
FRIESEN, B ;
MEEKISON, W .
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 1994, 148 (05) :495-502